Chembio Diagnostics is a biotechnology company based in Hauppauge, New York, which develops powerful diagnostic tools for medical applications worldwide. The company has a global network of offices to ensure that it can serve global customers, both from Germany and Brazil.
Chembio Diagnostics (NASDAQ: CEMI)
This time last year, CEMI traded at about the same price. It has seen a few spikes during that time related to news about the research, and it is currently recovering from a sale earlier this year.
Why is CEMI moving?
CEMI shares are currently on the move after Brazil ordered $ 28 million in COVID tests from the company. The rapid test was confirmed to be commercially viable in the spring, and this massive order increased investor confidence. Because COVID-1
Where can I buy Chembio Diagnostics Stock
Choose from the brokers listed below – Benzinga’s favorites – to invest in CEMI stocks. You can first invest slowly, increase your position, diversify your portfolio and build wealth using tools from any of these brokers.
Stay ahead of the game at CEMI
Use Benzinga Pro when you need investment information that will dramatically improve your life, increase your net worth and help you stay ahead of the game on CEMI and other stocks.
Data for Chembio Diagnostics from July 21, 2021
Summary of Chembio Diagnostics from July 21, 2021:
Important dates for Chembio Diagnostics:
Technical data for Chembio Diagnostics from 21 July 2021:
RSI: ⮕ 67.7824
MACD: Signal Line (-0.5347) Under MACD (-0.1691) ⮕ Bearish
Bollinger Bands: Price ($ 4.0), 20-Day SMA ($ 3.2983), Lower Band ($ 2.0137), Upper Band ($ 5.0769) øy Neutral
See more from Benzinga
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.